Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

December 14, 2017 - 4:31 p.m.
Gilead Sciences Announces That John C. Martin, PhD Will Transition From Executive Chairman to Chairman of the Board of DirectorsPrinter Friendly Version 
December 11, 2017 - 7:31 p.m.
Kite Announces Data From ZUMA-3 Study of KTE-C19 in Adult Patients with Relapsed or Refractory Acute Lymphoblastic LeukemiaPrinter Friendly Version 

Upcoming Events

There are currently no events scheduled.

Most Viewed Links

Updated 12/12/17
1.SEC Filings
2.Annual Reports
3.Earnings
4.Stock Information
5.Gilead Announces 10-Year, $100 Million Commitment to Address the HIV/AIDS Epidemic in the Southern United States
* Data collected 12/04/17 - 12/11/17

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$75.57
 Stock is Up 1.23 (1.65%)
Data as of 12/15/17 4:15 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Credit Suisse 26th Annual Healthcare Conference

November 07, 2017 12:30 p.m. MT
Play
Third Quarter 2017 Gilead Sciences Earnings Conference Call

October 26, 2017 4:30 p.m. ET
Play
Gilead Sciences at Morgan Stanley Global Healthcare Conference

September 11, 2017 9:55 a.m. ET
Play